Stephen J. Garry & Associates LLC Increases Stock Holdings in SPDR S&P Biotech ETF $XBI

Stephen J. Garry & Associates LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 191.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,745 shares of the exchange traded fund’s stock after buying an additional 4,430 shares during the quarter. SPDR S&P Biotech ETF accounts for 0.7% of Stephen J. Garry & Associates LLC’s investment portfolio, making the stock its 26th largest holding. Stephen J. Garry & Associates LLC’s holdings in SPDR S&P Biotech ETF were worth $862,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in SPDR S&P Biotech ETF during the 4th quarter worth $27,000. Intesa Sanpaolo Wealth Management purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $30,000. SHP Wealth Management purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $31,000. Legacy Wealth Managment LLC ID purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $32,000. Finally, Smartleaf Asset Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $32,000.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $140.72 on Monday. SPDR S&P Biotech ETF has a fifty-two week low of $80.90 and a fifty-two week high of $143.46. The stock has a market cap of $8.98 billion, a PE ratio of 11.47 and a beta of 0.85. The firm’s 50-day simple moving average is $133.56 and its 200 day simple moving average is $127.76.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.